Drug Database
A04AD12 aprepitant
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Aprepitant 125 mg hard capsules
- POM Aprepitant 80 mg and 125 mg hard capsules
- POM Aprepitant 80 mg hard capsules
- POM Aprepitant Accord 125mg hard capsules
- POM Aprepitant Accord 125mg/80mg hard capsules
- POM Aprepitant Accord 80mg hard capsules
- POM Aprepitant Ethypharm 125 mg hard capsules
- POM Aprepitant Ethypharm 80 mg hard capsules
- POM Aprepitant Mylan 80 mg hard capsules
- POM Aprepitant Mylan 80mg/125mg Hard Capsule
- POM Aprepitant Zentiva 125mg hard capsules
- POM Aprepitant Zentiva 125mg/80mg hard capsules
- POM Aprepitant Zentiva 80mg hard capsules
- POM EMEND 125 mg powder for oral suspension
- POM EMEND 125 mg powder for oral suspension (Northern Ireland)
- POM EMEND 80mg, 125mg hard Capsules
- POM Emend 80mg, 125mg Hard Capsules (Northern Ireland)
- POM IVEMEND 150 mg powder for solution for infusion
- POM IVEMEND 150 mg powder for solution for infusion (Northern Ireland)
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).